Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progesterone Receptor Negative”

446 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 446 results

Not applicableStudy completedNCT05736939
What this trial is testing

Gender Differences in the Recovery Rate Following PR in Patients With Long COVID-19

Who this might be right for
Post Acute COVID-19 Syndrome
National and Kapodistrian University of Athens 30
Not applicableLooking for participantsNCT06521944
What this trial is testing

RSV Vaccine Pregnancy Registry

Who this might be right for
Respiratory Syncytial Virus (RSV)
CorEvitas 2,062
Large-scale testing (Phase 3)Study completedNCT03232281
What this trial is testing

Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

Who this might be right for
Endometriosis
Ipsen 300
Post-approval studies (Phase 4)Study completedNCT01374763
What this trial is testing

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

Who this might be right for
Postoperative PainOpioid Related Disorders
Kati Järvelä 165
Testing effectiveness (Phase 2)Looking for participantsNCT04115306
What this trial is testing

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Phoenix Molecular Designs 61
Post-approval studies (Phase 4)Study completedNCT01494532
What this trial is testing

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 352
Early research (Phase 1)UnknownNCT02817932
What this trial is testing

Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Who this might be right for
Healthy Male Individuals
A.Menarini Asia-Pacific Holdings Pte Ltd 120
Early research (Phase 1)Study completedNCT01145430
What this trial is testing

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+7 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Testing effectiveness (Phase 2)Study completedNCT00580333
What this trial is testing

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 51
Not applicableActive Not RecruitingNCT03922932
What this trial is testing

WF and PR OCTA in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Oregon Health and Science University 290
Large-scale testing (Phase 3)Active Not RecruitingNCT00070564
What this trial is testing

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 3,294
Testing effectiveness (Phase 2)Study completedNCT00608972
What this trial is testing

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 31
Early research (Phase 1)Looking for participantsNCT06586957
What this trial is testing

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
NiKang Therapeutics, Inc. 150
Not applicableStudy completedNCT04573595
What this trial is testing

Fresenius Noninvasive Blood Pressure Validation

Who this might be right for
Blood Pressure
Fresenius Medical Care North America 159
Early research (Phase 1)Study completedNCT01971515
What this trial is testing

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
EMD Serono 101
Large-scale testing (Phase 3)UnknownNCT03687268
What this trial is testing

Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation

Who this might be right for
Opioid-Induced Constipation
Develco Pharma Schweiz AG 1,500
Testing effectiveness (Phase 2)Ended earlyNCT05618613
What this trial is testing

Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Context Therapeutics Inc. 4
Early research (Phase 1)Study completedNCT01238952
What this trial is testing

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Triple Negative Breast Cancer
Nippon Kayaku Co., Ltd. 4
Large-scale testing (Phase 3)Study completedNCT00164619
What this trial is testing

Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR

Who this might be right for
Sexually Transmitted Diseases
Centers for Disease Control and Prevention 3,660
Load More Results